$43.730
-0.455 (-1.04%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SUPN Prediction & Forecast by Similar Chart Analysis
Alphio's SUPN stock price prediction model matches the current Supernus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.19 (-5.80%). The 1-week path is $43.97 (+0.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Supernus Pharmaceuticals Inc Stock?
Supernus Pharmaceuticals Inc is currently a hold. The stock is priced at $43.73, significantly below the analyst price target of $67, indicating potential upside. However, the RSI is at a low 22.035, suggesting the stock is oversold, which could lead to a rebound. The recent merger with Indivior could provide long-term benefits, but the company reported a net loss of over $58 million in Q2, which raises concerns about profitability. Additionally, insider selling has surged by 2510.70%, indicating potential lack of confidence from insiders, which is a risk to consider.
SUPN stock price ended at $43.73 on Friday, after losing -1.04%
Supernus Pharmaceuticals Inc (SUPN) last closed at $43.73, losing -1.04%. These facts feed the 1-day and 1-week SUPN price prediction above.
Analyst Consensus
Supernus Pharmaceuticals Inc (SUPN): 6 buy, 2 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Supernus Pharmaceuticals Inc (SUPN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SUPN, ranked by similarity.
Seasonality analysis for SUPN
Historically the probability of a positive August return for SUPN is 66.67%. September offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SUPN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $27.38 | $29.28 | $33.82 | -33.05% |
| Sep 2026 | $25.93 | $29.28 | $30.36 | -33.05% |
| Oct 2026 | $32.04 | $39.52 | $40.25 | -9.63% |
| Nov 2026 | $29.48 | $29.51 | $33.72 | -32.51% |
| Dec 2026 | $22.31 | $29.28 | $33.77 | -33.05% |
In 2026, Supernus Pharmaceuticals Inc (SUPN) is projected to range from $22.31 to $40.25.
Supernus Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Supernus Pharmaceuticals Inc is projected to average $29.28, with a low of $27.38 and high of $33.82.
In Sep 2026, Supernus Pharmaceuticals Inc is projected to average $29.28, with a low of $25.93 and high of $30.36.
In Oct 2026, Supernus Pharmaceuticals Inc is projected to average $39.52, with a low of $32.04 and high of $40.25.
In Nov 2026, Supernus Pharmaceuticals Inc is projected to average $29.51, with a low of $29.48 and high of $33.72.
In Dec 2026, Supernus Pharmaceuticals Inc is projected to average $29.28, with a low of $22.31 and high of $33.77.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.